Detection of occult scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media

Journal of Clinical Microbiology

Volumn 48, Issue 1, 2010, Pages 314-316

  Blyth, C C ^a   Harun, A ^a   Middleton, P G ^a,b   Sleiman, S ^a   Lee, O ^a   Sorrell, T C ^a,b   Meyer, W ^a,b   Chen, S C A ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; GENTAMICIN;

ASPERGILLUS; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; NONHUMAN; NOTE; OUTPATIENT; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SCEDOSPORIUM;

CULTURE MEDIA; CYSTIC FIBROSIS; HUMANS; MYCOLOGY; MYCOSES; RESPIRATORY SYSTEM; SCEDOSPORIUM;

SCEDOSPORIUM; SCEDOSPORIUM AURANTIACUM;

EID: 73949115253     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01470-09     Document Type: Note

References (25)

1. Berenguer, J., J. L. Rodriguez-Tudela, C. Richard, M. Alvarez, M. A. Sanz, L. Gaztelurrutia, J. Ayats, and J. V. Martinez-Suarez. 1997. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Medicine (Baltimore) 76:256-265.
2. Blyth, C. C., P. G. Middleton, S. Sleiman, A. Harun, W. Meyer, T. C. Sorrell, and S. C.-A. Chen. 2009. Scedosporium spp. in cystic fibrosis (CF): emerging species and risk factors, abstr. M-1248. In Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
3. Bouchara, J. P., H. Y. Hsieh, S. Croquefer, R. Barton, V. Marchais, M. Pihet, and T. C. Chang. 2009. Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis. J. Clin. Microbiol. 47:142-152.
4. Cimon, B., J. Carrere, J. F. Vinatier, J. P. Chazalette, D. Chabasse, and J. P. Bouchara. 2000. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 19:53-56.
5. Cooley, L., D. Spelman, K. Thursky, and M. Slavin. 2007. Infection with Scedosporium apiospermum and S. prolificans, Australia. Emerg. Infect. Dis. 13:1170-1177.
6. Cortez, K. J., E. Roilides, F. Quiroz-Telles, J. Meletiadis, C. Antachopoulos, T. Knudsen, W. Buchanan, J. Milanovich, D. A. Sutton, A. Fothergill, M. G. Rinaldi, Y. R. Shea, T. Zaoutis, S. Kottilil, and T. J. Walsh. 2008. Infections caused by Scedosporium spp. Clin. Microbiol. Rev. 21:157-197.
7. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
8. Delhaes, L., A. Harun, S. C. Chen, Q. Nguyen, M. Slavin, C. H. Heath, K. Maszewska, C. Halliday, V. Robert, T. C. Sorrell, the AUSCEDO Study Group, and W. Meyer. 2008. Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum. Emerg. Infect. Dis. 14:282-290.
9. Gilgado, F., J. Cano, J. Gene, and J. Guarro. 2005. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J. Clin. Microbiol. 43:4930-4942.
10. Gilgado, F., J. Cano, J. Gene, D. A. Sutton, and J. Guarro. 2008. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J. Clin. Microbiol. 46:766-771.
11. Guignard, S., D. Hubert, B. Dupont, P. Anract, D. Alioua, H. Guerini, A. Paugam, and M. Dougados. 2008. Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. J. Cyst Fibros. 7:89-91.
12. Harun, A., F. Gilgado, S. C. Chen, and W. Meyer. 2009. Environmental isolation of Scedosporium species from the greater Sydney region: a link to the emergence of infections in Australia? Microbiol. Aust. 30:98-101.
13. Heath, C., M. Slavin, T. C. Sorrell, R. Handke, A. Harun, M. Philips, Q. Nguyen, L. Delhaes, D. Ellis, W. Meyer, and S. C. A. Chen. 2009. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin. Microbiol. Infect. 15:689-693.
14. Husain, S., P. Munoz, G. Forrest, B. D. Alexander, J. Somani, K. Brennan, M. M. Wagener, and N. Singh. 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin. Infect. Dis. 40:89-99.
15. Idigoras, P., E. Perez-Trallero, L. Pineiro, J. Larruskain, M. C. Lopez-Lopategui, N. Rodriguez, and J. M. Gonzalez. 2001. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin. Infect. Dis. 32:E158-E165.
16. Kaltseis, J., J. Rainer, and G. S. De Hoog. 2009. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples. Med. Mycol. 47:398-405.
17. Nagano, Y., B. C. Millar, E. Johnson, C. E. Goldsmith, J. S. Elborn, J. Rendall, and J. E. Moore. 2007. Fungal infections in patients with cystic fibrosis. Rev. Med. Microbiol. 18:11-16.
18. Orens, J. B., M. Estenne, S. Arcasoy, J. V. Conte, P. Corris, J. J. Egan, T. Egan, S. Keshavjee, C. Knoop, R. Kotloff, F. J. Martinez, S. Nathan, S. Palmer, A. Patterson, L. Singer, G. Snell, S. Studer, J. L. Vachiery, and A. R. Glanville. 2006. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 25:745-755.
19. Pihet, M., J. Carrere, B. Cimon, D. Chabasse, L. Delhaes, F. Symoens, and J. P. Bouchara. 2009. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review. Med. Mycol. 47:387-397.
20. Rainer, J., J. Kaltseis, S. G. de Hoog, and R. C. Summerbell. 2008. Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex. Antonie Van Leeuwenhoek 93:315-322.
21. Sahi, H., R. K. Avery, O. A. Minai, G. Hall, A. C. Mehta, P. Raina, and M. Budev. 2007. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J. Heart Lung Transplant. 26:350-356.
22. Singh, N., and D. L. Paterson. 2005. Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. 18:44-69.
23. Symoens, F., C. Knoop, M. Schrooyen, O. Denis, M. Estenne, N. Nolard, and F. Jacobs. 2006. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J. Heart Lung Transplant. 25:603-607.
24. Williamson, E. C., D. Speers, I. H. Arthur, G. Harnett, G. Ryan, and T. J. Inglis. 2001. Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease. J. Clin. Microbiol. 39:47-50.
25. Wood, G. M., J. G. McCormack, D. B. Muir, D. H. Ellis, M. F. Ridley, R. Pritchard, and M. Harrison. 1992. Clinical features of human infection with Scedosporium inflatum. Clin. Infect. Dis. 14:1027-1033.